We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.47B
Cap. Flow %
10.47%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.63%
2 Consumer Discretionary 12.48%
3 Communication Services 12.09%
4 Technology 9.72%
5 Industrials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELLI
1226
DELISTED
Ellie Mae Inc
ELLI
-39,440
Closed -$3.62M
ARRS
1227
DELISTED
ARRIS International plc Ordinary Shares
ARRS
-9,968
Closed -$209K
NTRI
1228
DELISTED
NutriSystem, Inc.
NTRI
-92,795
Closed -$2.35M
NXTM
1229
DELISTED
NxStage Medical Inc.
NXTM
-205,492
Closed -$4.46M
AHL
1230
DELISTED
ASPEN Insurance Holding Limited
AHL
-7,018
Closed -$325K
ATHN
1231
DELISTED
Athenahealth, Inc.
ATHN
-2,202
Closed -$304K
VVC
1232
DELISTED
Vectren Corporation
VVC
-8,646
Closed -$455K
DM
1233
DELISTED
Dominion Energy Midstream Ptr LP
DM
-18,870
Closed -$531K
SEP
1234
DELISTED
Spectra Engy Parters Lp
SEP
-159,027
Closed -$7.5M
FCE.A
1235
DELISTED
Forest City Realty Trust, Inc.
FCE.A
-187,612
Closed -$4.19M
COL
1236
DELISTED
Rockwell Collins
COL
-5,704
Closed -$486K
ETP
1237
DELISTED
Energy Transfer Partners, L.P.
ETP
-111,327
Closed -$3.2M
ILG
1238
DELISTED
ILG, Inc Common Stock
ILG
-71,184
Closed -$1.13M
IPXL
1239
DELISTED
Impax Laboratories, Inc.
IPXL
-8,729
Closed -$252K
BUFF
1240
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
-319,200
Closed -$7.45M
CCC
1241
DELISTED
Calgon Carbon Corp
CCC
-154,365
Closed -$2.03M
CAA
1242
DELISTED
CalAtlantic Group, Inc.
CAA
-40,635
Closed -$1.49M
SCMP
1243
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
-32,416
Closed -$356K
BSFT
1244
DELISTED
BroadSoft, Inc.
BSFT
-176,388
Closed -$7.24M
BETR
1245
DELISTED
Amplify Snack Brands, Inc.
BETR
-492,111
Closed -$7.26M
FIG
1246
DELISTED
Fortress Investment Group Llc
FIG
-79,271
Closed -$350K
TESO
1247
DELISTED
Tesco Corp
TESO
-355,171
Closed -$2.38M
PMC
1248
DELISTED
PharMerica Corporation
PMC
-30,466
Closed -$751K
ABCO
1249
DELISTED
Advisory Board Co
ABCO
-58,347
Closed -$2.06M
MORE
1250
DELISTED
Monogram Residential Trust, Inc.
MORE
-92,751
Closed -$947K

Similar funds

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.